Degarelix

In the US, Degarelix (degarelix systemic) is a member of the following drug classes: gonadotropin-releasing hormone antagonists, hormones/antineoplastics and is used to treat Prostate Cancer.

US matches:

• Degarelix


• Degarelix Acetate


• Degarelix Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02BX02

CAS registry number (Chemical Abstracts Service)

0214766-78-6

Chemical Formula

C82-H103-Cl-N18-O16

Molecular Weight

1632

Therapeutic Categories

Antineoplastic agent

Gonadotropin releasing hormone (GnRH) receptor antagonist

Chemical Names

D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N⁶-(1-methylethyl)-L-l (USAN)

N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-[[[(4S)-2,6-dioxohexahydroprymidin-4-yl]carbonyl]amino]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N⁶-(1-methylethyl)-L-lysyl-L-prolyl-D-alanin (WHO)

Foreign Names

• Degarelixum (Latin)
• Degarelix (German)
• Dégarélix (French)
• Degarelix (Spanish)

Generic Names

• Degarelix (OS: USAN)
• Degarelix Acetate (OS: USAN)
• ASP-3550 (IS)
• FE200486 (IS)

Brand Names

• Firmagon
  Ferring, Greece



• Degarelix for Injection
  Ferring, United States



• Firmagon
  Ferring, Austria; Ferring, Switzerland; Ferring, Germany; Ferring, France; Ferring, United Kingdom; Ferring, United States



• FIRMAGON
  Ferring, Sweden

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.